Current Context : India, South Korea, Japan, the US, and the European Union launched an alliance to put joint efforts to build a resilient supply chain in the biopharmaceutical sector.

• It was announced on the inaugural meeting of the Biopharmaceutical Alliance, during the Bio International Convention 2024, the world’s largest biopharmaceutical exhibition.
• It was held in San Diego, California.
• The alliance was launched in response to the drug supply shortages experienced during the Covid-19 pandemic.

ABOUT BIOPHARMACEUTICALS

• Biopharmaceuticals are a type of medical drug which is produced by using a living being’s organs and tissues, microorganisms, animal fluids, or genetically modified cells and organisms.

It uses biotechnology to produce drugs, which are mainly proteins and nucleic acids (DNA, RNA, or antisense oligonucleotides).